| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 24 |
| 1 | BEVACIZUMAB | 19 |
| 2 | METFORMIN | 19 |
| 3 | METFORMIN ER 500 MG | 19 |
| 4 | METFORMIN ER 750 MG | 19 |
| 5 | EVEROLIMUS | 17 |
| 6 | OMEPRAZOLE | 15 |
| 7 | OMEPRAZOLE MAGNESIUM | 15 |
| 8 | SUNITINIB MALATE | 15 |
| 9 | RITUXIMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROMOCRIPTINE MESYLATE | 2 | 0.0031 |
| 1 | OLOPATADINE HCL | 1 | 0.0027 |
| 2 | RIPRETINIB | 12 | 0.0023 |
| 3 | GAS RELIEF | 1 | 0.0020 |
| 4 | MESNA INJECTION | 12 | 0.0014 |
| 5 | MESNA | 12 | 0.0014 |
| 6 | PASIREOTIDE | 3 | 0.0013 |
| 7 | TAZEMETOSTAT | 2 | 0.0012 |
| 8 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 9 | RADIUM RA 223 DICHLORIDE | 5 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 4 | 0.0008 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 2 | Autologous Cellular Immunotherapy [EPC] | 2 | 0.0003 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 4 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 6 | Antiparasitic [EPC] | 1 | 0.0002 |
| 7 | Pediculicide [EPC] | 1 | 0.0002 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 10 | 0.0002 |
| 9 | Bismuth [EPC] | 1 | 0.0002 |